“Augmented cytotoxic, mutagenic and genotoxic response triggered by carvedilol and celecoxib combinations”, Braz. J. Pharm. Sci., vol. 54, no. 1, p. e17292, Jun. 2018, doi: 10.1590/s2175-97902018000117292.